YGION Biomedical, an Austrian biotechnology firm, is dedicated to transforming personalized cancer immunotherapy into reality. By harnessing advanced technologies, it aims to develop tailored treatments that empower patients in their battle against cancer, offering hope and improved outcomes through innovative therapeutic solutions.
National Ranking113th
in Philippines Regional Ranking1918th
in South East Asia Global Ranking52446th
worldwide Rankings by
